SCHEMBL30906411

SCHEMBL30906411

CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.72

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 19/20 0.72
▸ ECE1 P42892 1/20 0.66
▸ MUS81 Q96NY9 1/20 0.66
▸ IL23R Q5VWK5 1/20 0.61
▸ GCGR P47871 1/20 0.60
▸ GIPR P48546 1/20 0.60
▸ CCKBR P32239 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31000949 0.94 GLP1R (0.75) GLP1RECE1MUS81CCKBR
SCHEMBL30906555 0.94 GLP1R (0.68) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30906488 0.94 GLP1R (0.66) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30906510 0.94 GLP1R (0.67) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30979198 0.93 GLP1R (0.75) GLP1RECE1MUS81GCGRGIPR
SCHEMBL30906532 0.92 GLP1R (0.71) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30906511 0.92 GLP1R (0.71) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30906506 0.92 GLP1R (0.68) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30906486 0.92 GLP1R (0.70) GLP1RECE1MUS81IL23RCCKBR
SCHEMBL30986899 0.92 GLP1R (0.71) GLP1RECE1MUS81GCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback